Related Experiment Videos
[Reversible myelofibrosis in angioimmunoblastic lymphadenopathy]
T Orth1, U Treichel, W J Mayet
1I. Medizinische Klinik und Poliklinik, Universität Mainz.
Deutsche Medizinische Wochenschrift (1946)
|May 13, 1994
Summary
A rare case of angioimmunoblastic lymphadenopathy (AILD) in a woman led to swelling and anemia. Treatment with prednisone and vincristine achieved partial remission, improving AILD and myelofibrosis.
Area of Science:
- Hematology
- Oncology
Background:
- Angioimmunoblastic lymphadenopathy (AILD) is a rare, aggressive non-Hodgkin lymphoma.
- AILD can present with systemic symptoms and multiorgan involvement.
Observation:
- A 55-year-old woman presented with sudden onset ankle edema, abdominal swelling, and lymphadenopathy.
- Imaging revealed hepatosplenomegaly, ascites, and pleural effusions.
- Bone marrow biopsy showed normocytic anemia, thrombocytopenia, and lymphoma-associated secondary myelofibrosis.
Findings:
- Histological examination confirmed angioimmunoblastic lymphadenopathy (low-malignant peripheral T cell lymphoma).
- Treatment with prednisone and vincristine resulted in partial remission of AILD.
- Clinical and laboratory findings normalized, with regression of organomegaly and ascites.
- Bone marrow biopsy demonstrated regression of myelofibrosis four months post-treatment.
Implications:
- This case highlights the potential for AILD to cause significant systemic complications, including myelofibrosis.
- Combination chemotherapy with prednisone and vincristine can be effective in managing AILD and its associated complications.
- Early diagnosis and prompt treatment are crucial for improving outcomes in patients with AILD.